T Acute Lymphoblastic Leukemia — Trials

T Acute Lymphoblastic Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

117 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 47
Recruiting: 28
Ph III recruiting: 2
Growth YoY: —
Industry share: 9%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 52.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (22)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02619630	Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults (18-59 Years Old)(GRAALL-2014/T)	unknown	Phase 2	275	Assistance Publique - Hôpitaux de ParisOTHER	1	Oct 21, 2019	clinicaltrials
NCT03613428	Ruxolitinib Plus LVP in Patients With R/R ETP-ALL	unknown	Phase 1 / Phase 2	12	Sichuan UniversityOTHER	0	Aug 3, 2018	clinicaltrials